Westhampton Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.85M | Sell |
9,974
-200
| -2% | -$37.1K | 0.96% | 32 |
|
|
2025
Q1 | $2.13M | Hold |
10,174
| – | – | 1.16% | 25 |
|
|
2024
Q4 | $1.81M | Buy |
10,174
+1,365
| +15% | +$243K | 0.92% | 33 |
|
|
2024
Q3 | $1.74M | Hold |
8,809
| – | – | 0.88% | 39 |
|
|
2024
Q2 | $1.51M | Buy |
8,809
+1,000
| +13% | +$172K | 0.82% | 41 |
|
|
2024
Q1 | $1.42M | Sell |
7,809
-750
| -9% | -$137K | 0.78% | 47 |
|
|
2023
Q4 | $1.33M | Sell |
8,559
-1,735
| -17% | -$269K | 0.79% | 47 |
|
|
2023
Q3 | $1.53M | Sell |
10,294
-75
| -0.7% | -$11.2K | 0.99% | 36 |
|
|
2023
Q2 | $1.4M | Sell |
10,369
-65
| -0.6% | -$8.76K | 0.91% | 39 |
|
|
2023
Q1 | $1.66M | Buy |
10,434
+10
| +0.1% | +$1.59K | 1.07% | 29 |
|
|
2022
Q4 | $1.68M | Buy |
10,424
+135
| +1% | +$21.8K | 1.14% | 26 |
|
|
2022
Q3 | $1.38M | Buy |
10,289
+200
| +2% | +$26.8K | 1.04% | 30 |
|
|
2022
Q2 | $1.55M | Buy |
10,089
+40
| +0.4% | +$6.13K | 1.09% | 30 |
|
|
2022
Q1 | $1.63M | Buy |
10,049
+50
| +0.5% | +$8.11K | 1.05% | 31 |
|
|
2021
Q4 | $1.35M | Sell |
9,999
-870
| -8% | -$118K | 0.83% | 42 |
|
|
2021
Q3 | $1.17M | Buy |
10,869
+280
| +3% | +$30.2K | 0.8% | 43 |
|
|
2021
Q2 | $1.19M | Buy |
10,589
+450
| +4% | +$50.7K | 0.78% | 43 |
|
|
2021
Q1 | $1.1M | Buy |
10,139
+3,975
| +64% | +$430K | 0.76% | 42 |
|
|
2020
Q4 | $660K | Buy |
6,164
+215
| +4% | +$23K | 0.49% | 58 |
|
|
2020
Q3 | $521K | Buy |
5,949
+1,024
| +21% | +$89.7K | 0.43% | 64 |
|
|
2020
Q2 | $484K | Buy |
4,925
+655
| +15% | +$64.4K | 0.42% | 66 |
|
|
2020
Q1 | $325K | Buy |
4,270
+1,170
| +38% | +$89.1K | 0.34% | 73 |
|
|
2019
Q4 | $274K | Hold |
3,100
| – | – | 0.22% | 94 |
|
|
2019
Q3 | $235K | Sell |
3,100
-700
| -18% | -$53.1K | 0.2% | 99 |
|
|
2019
Q2 | $276K | Buy |
+3,800
| New | +$276K | 0.23% | 96 |
|